Find information on previous and upcoming congresses
View upcoming congresses and filter through abstracts, presentations, and posters from past congresses.

Upcoming congresses
2025 Hereditary Angioedema Association (HAEA) US Summit Congress
BioCryst will attend the 2025 Hereditary Angioedema Association (HAEA) US Summit Congress from July 10-13, 2025.
Browse our archive of congress materials
Filter
Showing 101 Materials
-
Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results From APeX-P
EAACI | 2025 | Hereditary Angioedema (HAE) -
Assessment of the Effectiveness and Tolerability of Berotralstat for Long-term Prophylaxis in Hereditary Angioedema: Findings from the Berolife Study
EAACI | 2025 | Hereditary Angioedema (HAE) -
Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results From a Focus Group
EAACI | 2025 | Hereditary Angioedema (HAE) -
Impact of Berotralstat on Quality of Life in Patients with Hereditary Angioedema
EAACI | 2025 | Hereditary Angioedema (HAE) -
Berotralstat for the Prevention of Hereditary Angioedema Attacks: Results from the Italian Expanded Access Programme
C1-INH Def Wkshp | 2025 | Hereditary Angioedema (HAE) -
Tolerability and Effectiveness of Berotralstat for Prophylaxis in Adolescents with Hereditary Angioedema: Subgroup Analysis of the Berolife Study
C1-INH Def Wkshp | 2025 | Hereditary Angioedema (HAE) -
Reduction in Percentage of Days With Angioedema Symptoms Among Young Children Initiating Berotralstat: Interim Results From APeX-P
C1-INH Def Wkshp | 2025 | Hereditary Angioedema (HAE) -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents
ISPOR | 2025 | Hereditary Angioedema (HAE) -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients with C1 Inhibitor Deficiency (Type I/II) and ≥8 Attacks Per Month
ISPOR | 2025 | Hereditary Angioedema (HAE) -
Exploring the Role of Disease Burden, Treatment Effectiveness, and Administration Preference on Willingness of Patients With HAE to Change Long-Term Prophylaxis
AAAAI | 2025 | Hereditary Angioedema (HAE)